Cancers, Free Full-Text
Por um escritor misterioso
Descrição
Imatinib became the standard treatment for chronic myeloid leukemia (CML) about 20 years ago, which was a major breakthrough in stabilizing the pathology and improving the quality of life of patients. However, the emergence of resistance to imatinib and other tyrosine kinase inhibitors leads researchers to characterize new therapeutic targets. Several studies have highlighted the role of histone deacetylase 6 (HDAC6) in various pathologies, including cancer. This protein effectively intervenes in cellular activities by its primarily cytoplasmic localization. In this review, we will discuss the molecular characteristics of the HDAC6 protein, as well as its overexpression in CML leukemic stem cells, which make it a promising therapeutic target for the treatment of CML.
Cancer Anniversary
Quantitative estimates of preventable and treatable deaths from 36 cancers worldwide: a population-based study - The Lancet Global Health
PDF) Predictors of recurrence free survival for patients with stage II and III colon cancer
Hypercalcemia and treated breast cancers: The diagnostic dilemma – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
Cancers, Free Full-Text
Free Breast Cancer Treatment - Colaboratory
Mortality after second malignancy in breast cancer survivors compared to a first primary cancer: a nationwide longitudinal cohort study
I Am Cancer Free - song and lyrics by ManifesTunes
Breast Cancer Awareness Month - National Breast Cancer Foundation
Journal of Cancer Research and Clinical Oncology
de
por adulto (o preço varia de acordo com o tamanho do grupo)
